Amag Pharmaceuticals Inc. (AMAG) SEC Filing 8-K Material Event for the period ending Friday, March 8, 2019

SEC Filings

Amag Pharmaceuticals Inc.

CIK: 792977 Ticker: AMAG

View differences made from one to another to evaluate Amag Pharmaceuticals Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Amag Pharmaceuticals Inc..


Assess how Amag Pharmaceuticals Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Amag Pharmaceuticals Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools

Material Contracts, Statements, Certifications & more

Amag Pharmaceuticals Inc. provided additional information to their SEC Filing as exhibits

Ticker: AMAG
CIK: 792977
Form Type: 8-K Corporate News
Accession Number: 0000792977-19-000050
Submitted to the SEC: Fri Mar 08 2019 8:04:04 AM EST
Accepted by the SEC: Fri Mar 08 2019
Period: Friday, March 8, 2019
Industry: Pharmaceutical Preparations
  1. Financial Exhibit
  2. Regulated Disclosure

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: